Obesity Treatment Market is
expected to experience an average growth in coming years between 2017 and 2025.
The market is expected to become $0.81 billion by 2025 at a slow CAGR of 4.72%.
The technological advancement to improve compliance rates of surgeries,
Government initiatives to increase awareness about fitness among people and
aggressive promotional activities to attract customers will be the major
driving factors of obesity treatment market. Obesity has become a common
phenomenon across the globe in all age groups. For instance, as per survey, in
US, adult obesity rates has exceeded more than 34% in five states, more than
28% in 26 states and more than 22% in 48 states in 2016.
Get Sample Copy of the Report here: https://www.crystalmarketresearch.com/report-sample/HC06102
Scope of the Report:
North
America held a significant share of the obesity treatment market in 2016 due to
the increase in obesity cases in various states. In addition, increase in
disposable income has also led to more adoption of obesity treatment by people.
The Asia-Pacific market has not experienced any substantial growth due to lack
of large scale adoption of advanced treatment for obesity management but can
experience favorable growth in coming years owing to increasing awareness and
changing lifestyles related to obesity management in the region.
Key Players Operating
In Global Market:
The
key players operating in the global obesity treatment market emphasize on
product development in order to introduce improve obesity treatment and capture
a larger share of the market. Some of the major players in this market
are, Allergan Plc, Medtronic, VIVUS, Inc., Atkins Nutritionals, Inc.,
EnteroMedics, Inc, F. Hoffmann-La Roche Ltd., Apollo Endosurgery, Inc., Novo
Nordisk A/S, USGI Medical, Inc., Ethicon (subsidiary of Johnson & Johnson),
Herbalife Ltd., Cousin Biotech, Johnson Health Technology, Ltd.,
Orexigen Therapeutics, and Technogym Spa.
Global
Obesity Treatment Market Segmentation:
By Drugs
Appetite
Suppressants
Satiety
Combination
Drugs
Malabsorption
By
Devices and Surgery
Roux-en-Y
Gastric Bypass
Biliopancreatic
Diversion with Duodenal Switch
Adjusting
Gastric Banding
Sleeve
Gastrostomy
Endoscopic
Procedures
Others
Speak to Experts
for any Queries: https://www.crystalmarketresearch.com/send-an-enquiry/HC06102
Comments
Post a Comment